• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Netherlands, an H3N2 flu virus with reduced sensitivity to antivirals detected in April 2012 (EuroFlu, edited)

Giuseppe

Emeritus
[Source: EuroFlu, full page: (LINK). Edited.]


EuroFlu - Weekly Electronic Bulletin - Week 24 : 11/06/2012-17/06/2012 - 22 June 2012, Issue N? 449

(...)


Country comments (where available)


Netherlands:

'In an A(H3N2) virus detected in a specimen collected in April 2012, an I222V substitution in the N2 was detected.

'I222V has previously been associated with slightly reduced susceptibility for neuraminidase inhibitors.

'However, in combination with E119V it has a synergistic effect on the resistance level against oseltamivir.

'Furthermore, it has a compensatory role in the replication of A(H3N2) viruses with the E119V substitution in N2.

'The patient presented with common cold, was vaccinated, not immunocompromised, and not exposed to antivirals, either through therapy or exposure to treated household contacts. Further characterisation of the virus is under way.'

(...)

-
------
 
Back
Top Bottom